Hema Edupuganti, MD in Gulfport, MS - Medicare Internal Medicine

Hema Edupuganti, MD is a medicare enrolled "Internal Medicine" physician in Gulfport, Mississippi. She went to Tulane University School Of Medicine and graduated in 1998 and has 26 years of diverse experience with area of expertise as Internal Medicine. She is a member of the group practice Memorial Hospital At Gulfport and her current practice location is 4500 13th St, Gulfport, Mississippi. You can reach out to her office (for appointments etc.) via phone at (228) 867-5201.

Hema Edupuganti is licensed to practice in Mississippi (license number 18308) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1881608115.

Contact Information

	Hema Edupuganti, MD
	4500 13th St, Gulfport, MS 39501-2515
	(228) 867-5201
	(228) 867-3152

Physician's Profile

Full Name	Hema Edupuganti
Gender	Female
Speciality	Internal Medicine
Experience	26 Years
Location	4500 13th St, Gulfport, Mississippi
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Hema Edupuganti attended and graduated from Tulane University School Of Medicine in 1998

NPI Data:

NPI Number: 1881608115
Provider Enumeration Date: 07/29/2006
Last Update Date: 10/12/2023

Medicare PECOS Information:

PECOS PAC ID: 4981592631
Enrollment ID: I20040305000440

Medical Identifiers

Medical identifiers for Hema Edupuganti such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881608115	NPI	-	NPPES
05480269	Medicaid	MS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	18308 (Mississippi)	Secondary
207R00000X	Internal Medicine	18308 (Mississippi)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Memorial Hospital At Gulfport	Gulfport, MS	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Memorial Hospital At Gulfport	2466524012	376

News Archive

Cotinine can reduce plaques linked with dementia and prevent memory loss

Cotinine, a compound derived from tobacco, reduced plaques associated with dementia and prevented memory loss in a mouse model of Alzheimer's disease, a study led by researchers at Bay Pines VA Healthcare System and the University of South Florida found.

New technology could revolutionize treatment of pediatric burns

Burns are one of the most common injuries suffered by Australians and one of the top causes of death in children under four. While survival rates for burns patients have improved substantially, treating paediatric burns remains challenging, especially with the rise of multi-drug resistant bacteria.

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Pretreatment interstitial lung disease (ILD) is a significant risk factor for developing symptomatic and severe radiation pneumonitis in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy (SBRT) alone.

Study finds high prevalence of severe mental disorders in prisons

Researchers have analyzed the cases of 1,328 patients sent to penitentiary psychiatric consultation by the medical services, the most comprehensive study conducted in Spain to date.

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

The U.S. Food and Drug Administration has granted qualified infectious disease product (QIDP) designation to two Bayer investigational agents, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI).

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Hema Edupuganti allows following entities to bill medicare on her behalf.

Entity Name	Memorial Hospital At Gulfport
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396

News Archive

Cotinine can reduce plaques linked with dementia and prevent memory loss

New technology could revolutionize treatment of pediatric burns

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Study finds high prevalence of severe mental disorders in prisons

Researchers have analyzed the cases of 1,328 patients sent to penitentiary psychiatric consultation by the medical services, the most comprehensive study conducted in Spain to date.

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hema Edupuganti is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Hema Edupuganti, MD Po Box 1810, Gulfport, MS 39502-1810 Ph: (228) 575-1194	Hema Edupuganti, MD 4500 13th St, Gulfport, MS 39501-2515 Ph: (228) 867-5201

News Archive

Cotinine can reduce plaques linked with dementia and prevent memory loss

New technology could revolutionize treatment of pediatric burns

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Study finds high prevalence of severe mental disorders in prisons

Researchers have analyzed the cases of 1,328 patients sent to penitentiary psychiatric consultation by the medical services, the most comprehensive study conducted in Spain to date.

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Internal Medicine Doctors in Gulfport, MS

Dr. Nabil Azar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave, Suite 310, Gulfport, MS 39501 Phone: 228-575-1400 Fax: 228-575-1414
Dr. Fahad Javed, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4215 15th St, Gulfport, MS 39501 Phone: 228-863-5211 Fax: 228-863-4101
Indrajit J Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152
James K. Campbell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15190 Community Rd Ste 240, Gulfport, MS 39503 Phone: 228-575-7104 Fax: 228-539-6766
Dr. Thomas Blanks, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-864-0425
Dr. Stephanie Fussell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1340 Broad Ave Ste 330, Gulfport, MS 39501 Phone: 228-575-1234 Fax: 228-867-4828
Dr. Malcolm Scott Dean, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152

Hema Edupuganti, MD - Medicare Internal Medicine in Gulfport, MS

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Cotinine can reduce plaques linked with dementia and prevent memory loss

New technology could revolutionize treatment of pediatric burns

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Study finds high prevalence of severe mental disorders in prisons

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Medicare Reassignments

Cotinine can reduce plaques linked with dementia and prevent memory loss

New technology could revolutionize treatment of pediatric burns

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Study finds high prevalence of severe mental disorders in prisons

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Cotinine can reduce plaques linked with dementia and prevent memory loss

New technology could revolutionize treatment of pediatric burns

Pretreatment ILD is a risk factor for developing radiation pneumonitis in stage I NSCLC patients

Study finds high prevalence of severe mental disorders in prisons

Bayer's Amikacin Inhale and Ciprofloxacin DPI receive QIDP designation from FDA

Internal Medicine Doctors in Gulfport, MS